Back to Aberdeen Group plc Aberdeen Group plc

BCRXBCRX
5 quarters

Position history for Aberdeen Group plcAberdeen Group plc's holdings in BIOCRYST PHARMACEUTICALS INC

Aberdeen Group plc holds 5.3M shares of BCRX (BIOCRYST PHARMACEUTICALS INC), worth $53.1M as of 2026-Q2. The position was increased (+5.4% shares). BCRX represents 0.1% of Aberdeen Group plc's portfolio.

Current Value

$53.1M

Current Shares

5.3M

Total Value Change

+$50.1M

Total Shares Change

+4.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
5.3M
+5.4%
$53.1M0.1%$10.00
31
2026-Q1
Increased
5M
+451.7%
$48M0.1%$9.52
47
2025-Q4
New
913,593
-
$7.1M0.0%$7.80
38
2024-Q1
Exited
0
-100.0%
$00.0%$5.08
0
2023-Q4
New
504,528
-
$3M0.0%$5.99
36

Other major holders of BCRX: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used